Denis Villeneuve reveals he does not have final cut on Blade Runner sequel
Director Denis Villeneuve has opened up about the Blade Runner sequel and has revealed that he does not have final cut on the movie.
Villeneuve, best known for his work on Sicario and Prisoners, has taken Ridley Scott's place in the director's chair, working from a script by Alien: Covenant scribe Michael Green and original co-writer Hampton Fancher.
Speaking to Variety about the film he said: "I agreed to do it because the producers behind Blade Runner [Broderick Johnson, Andrew A. Kosove] are two friends. I made Prisoners with them, and I knew the environment they would create around me would be very secure. I don’t really have final cut on it. The thing I realized about final cut, is it’s the power of the best cut."
He continued: "I didn’t have final cut on Prisoners, but what you saw is the best cut. Sicario is a directors’ cut, Arrival is a directors’ cut. I cannot talk about it, I will see. My relationship with the people I am working with is very strong. At the end of the day what will win is the best movie.
The original Blade Runner saw Scott battle studio executives over which cut to release and whether to include an explanatory voiceover at the start of the movie. Seven different cuts of the movie have been released over the years.
The sequel will star a returning Harrison Ford along with Dave Bautista, Jared Leto, Robin Wright, Barkhad Abdi and Ryan Gosling.
Plot details are being kept secret, but it is known that the new story will be set a number of decades after the completion of the original movie. Shooting on the sequel will get underway latet this month.
Earlier this year the sequel was brought forward, it originally was due to hit cinemas on January 12th in 2018, but has now moved up to October 6th in 2017.
Released in 1982, the original movie was set in a dystopian Los Angeles told the story of Ford's Rick Deckard, a man who hunts down genetically engineered androids visually indistinguishable from adult humans known as replicants.